DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Modeling Latently Infected Cell Activation: Viral and Latent Reservoir Persistence, and Viral Blips in HIV-infected Patients on Potent Therapy

Abstract

Although potent combination therapy is usually able to suppress plasma viral loads in HIV-1 patients to below the detection limit of conventional clinical assays, a low level of viremia frequently can be detected in plasma by more sensitive assays. Additionally, many patients experience transient episodes of viremia above the detection limit, termed viral blips, even after being on highly suppressive therapy for many years. An obstacle to viral eradication is the persistence of a latent reservoir for HIV-1 in resting memory CD4+ T cells. The mechanisms underlying low viral load persistence, slow decay of the latent reservoir, and intermittent viral blips are not fully characterized. The quantitative contributions of residual viral replication to viral and the latent reservoir persistence remain unclear. In this paper, we probe these issues by developing a mathematical model that considers latently infected cell activation in response to stochastic antigenic stimulation. We demonstrate that programmed expansion and contraction of latently infected cells upon immune activation can generate both low-level persistent viremia and intermittent viral blips. Also, a small fraction of activated T cells revert to latency, providing a potential to replenish the latent reservoir. By this means, occasional activation of latently infected cells can explain themore » variable decay characteristics of the latent reservoir observed in different clinical studies. Finally, we propose a phenomenological model that includes a logistic term representing homeostatic proliferation of latently infected cells. The model is simple but can robustly generate the multiphasic viral decline seen after initiation of therapy, as well as low-level persistent viremia and intermittent HIV-1 blips. Using these models, we provide a quantitative and integrated prospective into the long-term dynamics of HIV-1 and the latent reservoir in the setting of potent antiretroviral therapy.« less

Authors:
 [1];  [1];  [1]
  1. Los Alamos National Lab. (LANL), Los Alamos, NM (United States). Theoretical Biology and Biophysics
Publication Date:
Research Org.:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
USDOE Office of Science (SC), Biological and Environmental Research (BER). Biological Systems Science Division
OSTI Identifier:
1627194
Grant/Contract Number:  
AC52-06NA25396
Resource Type:
Accepted Manuscript
Journal Name:
PLoS Computational Biology (Online)
Additional Journal Information:
Journal Name: PLoS Computational Biology (Online); Journal Volume: 5; Journal Issue: 10; Journal ID: ISSN 1553-7358
Publisher:
Public Library of Science
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; 97 MATHEMATICS AND COMPUTING; Biochemistry & Molecular Biology; Mathematical & Computational Biology

Citation Formats

Rong, Libin, Perelson, Alan S., and Antia, Rustom. Modeling Latently Infected Cell Activation: Viral and Latent Reservoir Persistence, and Viral Blips in HIV-infected Patients on Potent Therapy. United States: N. p., 2009. Web. doi:10.1371/journal.pcbi.1000533.
Rong, Libin, Perelson, Alan S., & Antia, Rustom. Modeling Latently Infected Cell Activation: Viral and Latent Reservoir Persistence, and Viral Blips in HIV-infected Patients on Potent Therapy. United States. https://doi.org/10.1371/journal.pcbi.1000533
Rong, Libin, Perelson, Alan S., and Antia, Rustom. Fri . "Modeling Latently Infected Cell Activation: Viral and Latent Reservoir Persistence, and Viral Blips in HIV-infected Patients on Potent Therapy". United States. https://doi.org/10.1371/journal.pcbi.1000533. https://www.osti.gov/servlets/purl/1627194.
@article{osti_1627194,
title = {Modeling Latently Infected Cell Activation: Viral and Latent Reservoir Persistence, and Viral Blips in HIV-infected Patients on Potent Therapy},
author = {Rong, Libin and Perelson, Alan S. and Antia, Rustom},
abstractNote = {Although potent combination therapy is usually able to suppress plasma viral loads in HIV-1 patients to below the detection limit of conventional clinical assays, a low level of viremia frequently can be detected in plasma by more sensitive assays. Additionally, many patients experience transient episodes of viremia above the detection limit, termed viral blips, even after being on highly suppressive therapy for many years. An obstacle to viral eradication is the persistence of a latent reservoir for HIV-1 in resting memory CD4+ T cells. The mechanisms underlying low viral load persistence, slow decay of the latent reservoir, and intermittent viral blips are not fully characterized. The quantitative contributions of residual viral replication to viral and the latent reservoir persistence remain unclear. In this paper, we probe these issues by developing a mathematical model that considers latently infected cell activation in response to stochastic antigenic stimulation. We demonstrate that programmed expansion and contraction of latently infected cells upon immune activation can generate both low-level persistent viremia and intermittent viral blips. Also, a small fraction of activated T cells revert to latency, providing a potential to replenish the latent reservoir. By this means, occasional activation of latently infected cells can explain the variable decay characteristics of the latent reservoir observed in different clinical studies. Finally, we propose a phenomenological model that includes a logistic term representing homeostatic proliferation of latently infected cells. The model is simple but can robustly generate the multiphasic viral decline seen after initiation of therapy, as well as low-level persistent viremia and intermittent HIV-1 blips. Using these models, we provide a quantitative and integrated prospective into the long-term dynamics of HIV-1 and the latent reservoir in the setting of potent antiretroviral therapy.},
doi = {10.1371/journal.pcbi.1000533},
journal = {PLoS Computational Biology (Online)},
number = 10,
volume = 5,
place = {United States},
year = {Fri Oct 16 00:00:00 EDT 2009},
month = {Fri Oct 16 00:00:00 EDT 2009}
}

Works referenced in this record:

Antigen-driven CD4+ T cell and HIV-1 dynamics: Residual viral replication under highly active antiretroviral therapy
journal, December 1999

  • Ferguson, N. M.; deWolf, F.; Ghani, A. C.
  • Proceedings of the National Academy of Sciences, Vol. 96, Issue 26
  • DOI: 10.1073/pnas.96.26.15167

Duration of an intermittent episode of viremia
journal, July 2005


Drug concentration heterogeneity facilitates the evolution of drug resistance
journal, September 1998

  • Kepler, T. B.; Perelson, A. S.
  • Proceedings of the National Academy of Sciences, Vol. 95, Issue 20
  • DOI: 10.1073/pnas.95.20.11514

In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency
journal, December 1995

  • Chun, Tae-Wook; Finzi, Diana; Margolick, Joseph
  • Nature Medicine, Vol. 1, Issue 12
  • DOI: 10.1038/nm1295-1284

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
journal, March 2008

  • Palmer, S.; Maldarelli, F.; Wiegand, A.
  • Proceedings of the National Academy of Sciences, Vol. 105, Issue 10
  • DOI: 10.1073/pnas.0800050105

Recruitment Times, Proliferation, and Apoptosis Rates during the CD8+ T-Cell Response to Lymphocytic Choriomeningitis Virus
journal, November 2001


Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells
journal, May 2001

  • Kaech, Susan M.; Ahmed, Rafi
  • Nature Immunology, Vol. 2, Issue 5
  • DOI: 10.1038/87720

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
journal, June 2009

  • Chomont, Nicolas; El-Far, Mohamed; Ancuta, Petronela
  • Nature Medicine, Vol. 15, Issue 8
  • DOI: 10.1038/nm.1972

Modeling HIV persistence, the latent reservoir, and viral blips
journal, September 2009


Prevalence and Predictive Value of Intermittent Viremia with Combination HIV Therapy
journal, August 2001


HIV-1 dynamics in vivo: implications for therapy
journal, December 2003

  • Simon, Viviana; Ho, David D.
  • Nature Reviews Microbiology, Vol. 1, Issue 3
  • DOI: 10.1038/nrmicro772

Decay characteristics of HIV-1-infected compartments during combination therapy
journal, May 1997

  • Perelson, Alan S.; Essunger, Paulina; Cao, Yunzhen
  • Nature, Vol. 387, Issue 6629
  • DOI: 10.1038/387188a0

Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques
journal, November 2007

  • Chen, H. Y.; Di Mascio, M.; Perelson, A. S.
  • Proceedings of the National Academy of Sciences, Vol. 104, Issue 48
  • DOI: 10.1073/pnas.0707449104

The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to < 400 copies/ml
journal, January 2002


Monotypic Human Immunodeficiency Virus Type 1 Genotypes across the Uterine Cervix and in Blood Suggest Proliferation of Cells with Provirus
journal, April 2009

  • Bull, Marta E.; Learn, Gerald H.; McElhone, Scott
  • Journal of Virology, Vol. 83, Issue 12
  • DOI: 10.1128/jvi.02664-08

Viral and Latent Reservoir Persistence in HIV-1–Infected Patients on Therapy
journal, January 2006


Opportunistic infection as a cause of transient viremia in chronically infected HIV patients under treatment with HAART
journal, November 2005


Effect of Treatment, during Primary Infection, on Establishment and Clearance of Cellular Reservoirs of HIV-1
journal, May 2005

  • Strain, Matthew C.; Little, Susan J.; Daar, Eric S.
  • The Journal of Infectious Diseases, Vol. 191, Issue 9
  • DOI: 10.1086/428777

Different Dynamics of CD4 + and CD8 + T Cell Responses During and After Acute Lymphocytic Choriomeningitis Virus Infection
journal, October 2003


Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy
journal, January 1999


Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy
journal, January 1999


Intensification of Antiretroviral Therapy Accelerates the Decay of the HIV-1 Latent Reservoir and Decreases, But Does Not Eliminate, Ongoing Virus Replication
journal, January 2004


Intermittent HIV-1 Viremia (Blips) and Drug Resistance in Patients Receiving HAART
journal, February 2005


Density-Dependent Decay in HIV-1 Dynamics
journal, January 2006


Genotypic Analysis of HIV‐1 Drug Resistance at the Limit of Detection: Virus Production without Evolution in Treated Adults with Undetectable HIV Loads
journal, April 2004

  • Kieffer, Tara L.; Finucane, Mariel M.; Nettles, Richard E.
  • The Journal of Infectious Diseases, Vol. 189, Issue 8
  • DOI: 10.1086/382488

Reservoirs for HIV-1: Mechanisms for Viral Persistence in the Presence of Antiviral Immune Responses and Antiretroviral Therapy
journal, April 2000


Generation of HIV latency during thymopoiesis
journal, April 2001

  • Brooks, David G.; Kitchen, Scott G.; Kitchen, Christina M. R.
  • Nature Medicine, Vol. 7, Issue 4
  • DOI: 10.1038/86531

New Real-Time Reverse Transcriptase-Initiated PCR Assay with Single-Copy Sensitivity for Human Immunodeficiency Virus Type 1 RNA in Plasma
journal, October 2003


HIV rebounds from latently infected cells, rather than from continuing low-level replication
text, January 2008

  • Joos, B.; Fischer, M.; Kuster, H.
  • National Academy of Sciences
  • DOI: 10.5167/uzh-5181

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
journal, May 2003

  • Siliciano, Janet D.; Kajdas, Joleen; Finzi, Diana
  • Nature Medicine, Vol. 9, Issue 6
  • DOI: 10.1038/nm880

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
journal, May 1999

  • Finzi, Diana; Blankson, Joel; Siliciano, Janet D.
  • Nature Medicine, Vol. 5, Issue 5
  • DOI: 10.1038/8394

Viral and Latent Reservoir Persistence in HIV-1–Infected Patients on Therapy
journal, January 2006


Decay of the HIV Reservoir in Patients Receiving Antiretroviral Therapy for Extended Periods: Implications for Eradication of Virus
journal, June 2007

  • Chun, Tae‐Wook; Justement, J. Shawn; Moir, Susan
  • The Journal of Infectious Diseases, Vol. 195, Issue 12
  • DOI: 10.1086/518250

Transient Relapses (“Blips”) of Plasma HIV RNA Levels During HAART Are Associated With Drug Resistance
journal, January 2001

  • Cohen Stuart, James W. T.; Wensing, Annemarie M. J.; Kovacs, Colin
  • JAIDS Journal of Acquired Immune Deficiency Syndromes, Vol. 28, Issue 2
  • DOI: 10.1097/00126334-200110010-00001

ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia
journal, January 2007


Latent reservoirs of HIV: Obstacles to the eradication of virus
journal, September 1999

  • Chun, T. -W.; Fauci, A. S.
  • Proceedings of the National Academy of Sciences, Vol. 96, Issue 20
  • DOI: 10.1073/pnas.96.20.10958

Induction of HIV-1 Replication in Latently Infected CD4 + T Cells Using a Combination of Cytokines
journal, July 1998

  • Chun, Tae-Wook; Engel, Delphine; Mizell, Stephanie B.
  • The Journal of Experimental Medicine, Vol. 188, Issue 1
  • DOI: 10.1084/jem.188.1.83

Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: Intrinsic stability predicts lifelong persistence
journal, April 2003

  • Strain, M. C.; Gunthard, H. F.; Havlir, D. V.
  • Proceedings of the National Academy of Sciences, Vol. 100, Issue 8
  • DOI: 10.1073/pnas.0736332100

Duration of an intermittent episode of viremia
journal, July 2005


In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency
journal, December 1995

  • Chun, Tae-Wook; Finzi, Diana; Margolick, Joseph
  • Nature Medicine, Vol. 1, Issue 12
  • DOI: 10.1038/nm1295-1284

The role of antigenic stimulation and cytotoxic T cell activity in regulating the long–term immunopathogenesis of HIV: mechanisms and clinical implications
journal, October 2001

  • Frazer, Christophe; Ferguson, Neil M.; Wolf, Frank de
  • Proceedings of the Royal Society of London. Series B: Biological Sciences, Vol. 268, Issue 1481
  • DOI: 10.1098/rspb.2001.1777

Duration of TCR Stimulation Determines Costimulatory Requirement of T Cells
journal, July 1996


Modeling the Effects of Vaccination on Chronically Infected HIV-Positive Patients
journal, January 2002


Long‐Term Persistence of Transmitted HIV Drug Resistance in Male Genital Tract Secretions: Implications for Secondary Transmission
journal, August 2007

  • Smith, Davey M.; Wong, Joseph K.; Shao, Hai
  • The Journal of Infectious Diseases, Vol. 196, Issue 3
  • DOI: 10.1086/519164

Effector and memory T-cell differentiation: implications for vaccine development
journal, April 2002

  • Kaech, Susan M.; Wherry, E. John; Ahmed, Rafi
  • Nature Reviews Immunology, Vol. 2, Issue 4
  • DOI: 10.1038/nri778

Latent reservoirs of HIV: Obstacles to the eradication of virus
journal, September 1999

  • Chun, T. -W.; Fauci, A. S.
  • Proceedings of the National Academy of Sciences, Vol. 96, Issue 20
  • DOI: 10.1073/pnas.96.20.10958

Different Dynamics of CD4 + and CD8 + T Cell Responses During and After Acute Lymphocytic Choriomeningitis Virus Infection
journal, October 2003


Drug concentration heterogeneity facilitates the evolution of drug resistance
journal, September 1998

  • Kepler, T. B.; Perelson, A. S.
  • Proceedings of the National Academy of Sciences, Vol. 95, Issue 20
  • DOI: 10.1073/pnas.95.20.11514

Limits on Replenishment of the Resting CD4+ T Cell Reservoir for HIV in Patients on HAART
journal, August 2007


HIV-1 dynamics in vivo: implications for therapy
journal, December 2003

  • Simon, Viviana; Ho, David D.
  • Nature Reviews Microbiology, Vol. 1, Issue 3
  • DOI: 10.1038/nrmicro772

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
journal, May 2009

  • Dinoso, J. B.; Kim, S. Y.; Wiegand, A. M.
  • Proceedings of the National Academy of Sciences, Vol. 106, Issue 23
  • DOI: 10.1073/pnas.0903107106

Modeling HIV persistence, the latent reservoir, and viral blips
journal, September 2009


Viral Dynamics in HIV-1 Infection
journal, May 1998


Density-Dependent Decay in HIV-1 Dynamics
journal, January 2006


Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells
journal, June 2003

  • Seddon, Benedict; Tomlinson, Peter; Zamoyska, Rose
  • Nature Immunology, Vol. 4, Issue 7
  • DOI: 10.1038/ni946

Transient Relapses (“Blips”) of Plasma HIV RNA Levels During HAART Are Associated With Drug Resistance
journal, January 2001

  • Cohen Stuart, James W. T.; Wensing, Annemarie M. J.; Kovacs, Colin
  • JAIDS Journal of Acquired Immune Deficiency Syndromes, Vol. 28, Issue 2
  • DOI: 10.1097/00042560-200110010-00001

Evolution of Envelope Sequences of Human Immunodeficiency Virus Type 1 in Cellular Reservoirs in the Setting of Potent Antiviral Therapy
journal, November 1999


Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis
journal, November 1999


HIV-1 Infection and Low Steady State Viral Loads
journal, January 2002


Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
journal, May 2003

  • Siliciano, Janet D.; Kajdas, Joleen; Finzi, Diana
  • Nature Medicine, Vol. 9, Issue 6
  • DOI: 10.1038/nm880

Deep Gene Sequence Cluster Analyses of Multi-Virus-Infected Mucosal Tissue Reveal Enhanced Transmission of Acute HIV-1
journal, January 2021

  • Klein, Katja; Nankya, Immaculate; Nickel, Gabrielle
  • Journal of Virology, Vol. 95, Issue 3
  • DOI: 10.1128/jvi.01737-20

The Challenge of Finding a Cure for HIV Infection
journal, March 2009


Rapid Turnover of T Lymphocytes in SIV-Infected Rhesus Macaques
journal, February 1998


Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
text, January 1997

  • Jeffrey, Chodakewitz,; W., Mellors, John; Anne, Meibohm,
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/jktw-4q62

HIV rebounds from latently infected cells, rather than from continuing low-level replication
journal, October 2008

  • Joos, B.; Fischer, M.; Kuster, H.
  • Proceedings of the National Academy of Sciences, Vol. 105, Issue 43
  • DOI: 10.1073/pnas.0804192105

Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory
journal, August 2001

  • Homann, Dirk; Teyton, Luc; Oldstone, Michael B. A.
  • Nature Medicine, Vol. 7, Issue 8
  • DOI: 10.1038/90950

Dynamics of HIV infection of CD4+ T cells
journal, March 1993


Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: Intrinsic stability predicts lifelong persistence
journal, April 2003

  • Strain, M. C.; Gunthard, H. F.; Havlir, D. V.
  • Proceedings of the National Academy of Sciences, Vol. 100, Issue 8
  • DOI: 10.1073/pnas.0736332100

Effect of Influenza Vaccination on Viral Replication and Immune Response in Persons Infected with Human Immunodeficiency Virus Receiving Potent Antiretroviral Therapy
journal, February 2000

  • Günthard, Huldrych F.; Wong, Joseph K.; Spina, Celsa A.
  • The Journal of Infectious Diseases, Vol. 181, Issue 2
  • DOI: 10.1086/315260

Transient Viremia, Plasma Viral Load, and Reservoir Replenishment in HIV-Infected Patients on Antiretroviral Therapy
journal, January 2007

  • Jones, Laura E.; Perelson, Alan S.
  • JAIDS Journal of Acquired Immune Deficiency Syndromes, Vol. 45, Issue 5
  • DOI: 10.1097/qai.0b013e3180654836

The Duration of Antigenic Stimulation Determines the Fate of Naive and Effector T Cells
journal, January 1998


Two Distinct Stages in the Transition from Naive CD4 T Cells to Effectors, Early Antigen-Dependent and Late Cytokine-Driven Expansion and Differentiation
journal, November 2000


Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy
journal, May 1999

  • Zhang, Linqi; Ramratnam, Bharat; Tenner-Racz, Klara
  • New England Journal of Medicine, Vol. 340, Issue 21
  • DOI: 10.1056/NEJM199905273402101

Immune responses to Listeria monocytogenes
journal, October 2004

  • Pamer, Eric G.
  • Nature Reviews Immunology, Vol. 4, Issue 10
  • DOI: 10.1038/nri1461

The Challenge of Viral Reservoirs in HIV-1 Infection
journal, February 2002


Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1
text, January 2005

  • Strain, Matthew C.; Little, Susan J.; Daar, Eric S.
  • Oxford University Press
  • DOI: 10.5167/uzh-154177

Decelerating Decay of Latently Infected Cells during Prolonged Therapy for Human Immunodeficiency Virus Type 1 Infection
journal, September 2002


Treatment Implications of the Latent Reservoir for HIV‐1
book, January 2007


Long‐Term Persistence of Transmitted HIV Drug Resistance in Male Genital Tract Secretions: Implications for Secondary Transmission
journal, August 2007

  • Smith, Davey M.; Wong, Joseph K.; Shao, Hai
  • The Journal of Infectious Diseases, Vol. 196, Issue 3
  • DOI: 10.1086/519164

The role of antigenic stimulation and cytotoxic T cell activity in regulating the long–term immunopathogenesis of HIV: mechanisms and clinical implications
journal, October 2001

  • Frazer, Christophe; Ferguson, Neil M.; Wolf, Frank de
  • Proceedings of the Royal Society of London. Series B: Biological Sciences, Vol. 268, Issue 1481
  • DOI: 10.1098/rspb.2001.1777

A long-term latent reservoir for HIV-1: discovery and clinical implications
journal, June 2004

  • Siliciano, J. D.
  • Journal of Antimicrobial Chemotherapy, Vol. 54, Issue 1
  • DOI: 10.1093/jac/dkh292

HIV-1 Infection and Low Steady State Viral Loads
journal, January 2002


Intermittent HIV-1 Viremia (Blips) and Drug Resistance in Patients Receiving HAART
journal, February 2005


Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
journal, September 1997


A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
journal, September 1997

  • Hammer, Scott M.; Squires, Kathleen E.; Hughes, Michael D.
  • New England Journal of Medicine, Vol. 337, Issue 11
  • DOI: 10.1056/NEJM199709113371101

Rapid Turnover of T Lymphocytes in SIV-Infected Rhesus Macaques
journal, February 1998


Constant Mean Viral Copy Number per Infected Cell in Tissues Regardless of High, Low, or Undetectable Plasma HIV RNA
journal, May 1999

  • Hockett, Richard D.; Michael Kilby, J.; Derdeyn, Cynthia A.
  • The Journal of Experimental Medicine, Vol. 189, Issue 10
  • DOI: 10.1084/jem.189.10.1545

The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to < 400 copies/ml
journal, January 2002


Residual Human Immunodeficiency Virus (HIV) Type 1 RNA and DNA in Lymph Nodes and HIV RNA in Genital Secretions and in Cerebrospinal Fluid after Suppression of Viremia for 2 Years
journal, May 2001

  • Günthard, Huldrych F.; Havlir, Diane V.; Fiscus, Susan
  • The Journal of Infectious Diseases, Vol. 183, Issue 9
  • DOI: 10.1086/319864

The Challenge of Viral Reservoirs in HIV-1 Infection
journal, February 2002


Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy
journal, January 2002


Viral and Latent Reservoir Persistence in HIV-1 Infected Patients on Therapy
journal, January 2005


Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
journal, November 1997

  • Chun, T. -W.; Stuyver, L.; Mizell, S. B.
  • Proceedings of the National Academy of Sciences, Vol. 94, Issue 24
  • DOI: 10.1073/pnas.94.24.13193

Antigen-driven CD4+ T cell and HIV-1 dynamics: Residual viral replication under highly active antiretroviral therapy
journal, December 1999

  • Ferguson, N. M.; deWolf, F.; Ghani, A. C.
  • Proceedings of the National Academy of Sciences, Vol. 96, Issue 26
  • DOI: 10.1073/pnas.96.26.15167

Effect of Influenza Vaccination on Viral Replication and Immune Response in Persons Infected with Human Immunodeficiency Virus Receiving Potent Antiretroviral Therapy
journal, February 2000

  • Günthard, Huldrych F.; Wong, Joseph K.; Spina, Celsa A.
  • The Journal of Infectious Diseases, Vol. 181, Issue 2
  • DOI: 10.1086/315260

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
journal, March 2008

  • Palmer, S.; Maldarelli, F.; Wiegand, A.
  • Proceedings of the National Academy of Sciences, Vol. 105, Issue 10
  • DOI: 10.1073/pnas.0800050105

HIV rebounds from latently infected cells, rather than from continuing low-level replication
journal, October 2008

  • Joos, B.; Fischer, M.; Kuster, H.
  • Proceedings of the National Academy of Sciences, Vol. 105, Issue 43
  • DOI: 10.1073/pnas.0804192105

Residual Human Immunodeficiency Virus (HIV) Type 1 RNA and DNA in Lymph Nodes and HIV RNA in Genital Secretions and in Cerebrospinal Fluid after Suppression of Viremia for 2 Years
journal, May 2001

  • Günthard, Huldrych F.; Havlir, Diane V.; Fiscus, Susan
  • The Journal of Infectious Diseases, Vol. 183, Issue 9
  • DOI: 10.1086/319864

Viral Blip Dynamics during Highly Active Antiretroviral Therapy
journal, November 2003


Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy
journal, February 2001


Immunological Memory and Protective Immunity: Understanding Their Relation
journal, April 1996


HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
journal, June 2009

  • Chomont, Nicolas; El-Far, Mohamed; Ancuta, Petronela
  • Nature Medicine, Vol. 15, Issue 8
  • DOI: 10.1038/nm.1972

Reservoirs for HIV-1: Mechanisms for Viral Persistence in the Presence of Antiviral Immune Responses and Antiretroviral Therapy
journal, April 2000


Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
journal, November 1997

  • Chun, T. -W.; Stuyver, L.; Mizell, S. B.
  • Proceedings of the National Academy of Sciences, Vol. 94, Issue 24
  • DOI: 10.1073/pnas.94.24.13193

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
journal, May 1997

  • Chun, Tae-Wook; Carruth, Lucy; Finzi, Diana
  • Nature, Vol. 387, Issue 6629
  • DOI: 10.1038/387183a0

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
journal, May 1999

  • Finzi, Diana; Blankson, Joel; Siliciano, Janet D.
  • Nature Medicine, Vol. 5, Issue 5
  • DOI: 10.1038/8394

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
journal, May 2009

  • Dinoso, J. B.; Kim, S. Y.; Wiegand, A. M.
  • Proceedings of the National Academy of Sciences, Vol. 106, Issue 23
  • DOI: 10.1073/pnas.0903107106

Opportunistic infection as a cause of transient viremia in chronically infected HIV patients under treatment with HAART
journal, November 2005


Effector and memory T-cell differentiation: implications for vaccine development
journal, April 2002

  • Kaech, Susan M.; Wherry, E. John; Ahmed, Rafi
  • Nature Reviews Immunology, Vol. 2, Issue 4
  • DOI: 10.1038/nri778

Genotypic Analysis of HIV‐1 Drug Resistance at the Limit of Detection: Virus Production without Evolution in Treated Adults with Undetectable HIV Loads
journal, April 2004

  • Kieffer, Tara L.; Finucane, Mariel M.; Nettles, Richard E.
  • The Journal of Infectious Diseases, Vol. 189, Issue 8
  • DOI: 10.1086/382488

Modeling the Effects of Vaccination on Chronically Infected HIV-Positive Patients
journal, January 2002


Low-level HIV-1 replication and the dynamics of the resting CD4+T cell reservoir for HIV-1 in the setting of HAART
journal, January 2008

  • Sedaghat, Ahmad R.; Siliciano, Robert F.; Wilke, Claus O.
  • BMC Infectious Diseases, Vol. 8, Issue 1
  • DOI: 10.1186/1471-2334-8-2

Limits on Replenishment of the Resting CD4+ T Cell Reservoir for HIV in Patients on HAART
journal, August 2007


Two Distinct Stages in the Transition from Naive CD4 T Cells to Effectors, Early Antigen-Dependent and Late Cytokine-Driven Expansion and Differentiation
journal, November 2000


Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques
journal, November 2007

  • Chen, H. Y.; Di Mascio, M.; Perelson, A. S.
  • Proceedings of the National Academy of Sciences, Vol. 104, Issue 48
  • DOI: 10.1073/pnas.0707449104

Works referencing / citing this record:

Reduced evolutionary rates in HIV-1 reveal extensive latency periods among replicating lineages
journal, October 2014


Pyroptosis, superinfection, and the maintenance of the latent reservoir in HIV-1 infection
journal, June 2017


Residual Viremia in Treated HIV+ Individuals
journal, January 2016


Hybrid spreading mechanisms and T cell activation shape the dynamics of HIV-1 infection
text, January 2015


Modeling the within-host dynamics of HIV infection
journal, September 2013


Viral Blips After Treatment Initiation During Acute Human Immunodeficiency Virus Infection
journal, September 2019

  • Crowell, Trevor A.; Pinyakorn, Suteeraporn; Sacdalan, Carlo
  • Clinical Infectious Diseases, Vol. 70, Issue 12
  • DOI: 10.1093/cid/ciz936

Immediate antiviral therapy appears to restrict resting CD4 + cell HIV-1 infection without accelerating the decay of latent infection
text, January 2012

  • N. M., Archin,; J. M., Coffin,; A., Wiegand,
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/7wr7-m303

Effects of Eclipse Phase and Delay on the Dynamics of HIV Infection
journal, September 2018


Phylogenetic approach to recover integration dates of latent HIV sequences within-host
journal, September 2018

  • Jones, Bradley R.; Kinloch, Natalie N.; Horacsek, Joshua
  • Proceedings of the National Academy of Sciences, Vol. 115, Issue 38
  • DOI: 10.1073/pnas.1802028115

Epstein–Barr Virus: Diseases Linked to Infection and Transformation
journal, October 2016


A Highly Intensified ART Regimen Induces Long-Term Viral Suppression and Restriction of the Viral Reservoir in a Simian AIDS Model
journal, June 2012


Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection
text, January 2012

  • D., Kuruc, J.; S., Cohen, M.; M., Coffin, J.
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/n6wn-ha56

Dynamics of Cellular HIV-1 DNA Levels Over 144 Weeks of Darunavir/Ritonavir Monotherapy Versus Triple Therapy in the MONET Trial
journal, February 2013

  • Geretti, Anna Maria; Arribas, Jose R.; Lathouwers, Erkki
  • HIV Clinical Trials, Vol. 14, Issue 1
  • DOI: 10.1310/hct1401-45

Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV/AIDS
journal, June 2015


The role of integration and clonal expansion in HIV infection: live long and prosper
journal, October 2018


A mathematical model describing the localization and spread of influenza A virus infection within the human respiratory tract
journal, April 2020


Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection
journal, May 2012

  • Archin, N. M.; Vaidya, N. K.; Kuruc, J. D.
  • Proceedings of the National Academy of Sciences, Vol. 109, Issue 24
  • DOI: 10.1073/pnas.1120248109

Quantifying the Turnover of Transcriptional Subclasses of HIV-1-Infected Cells
journal, October 2014


Anti-proliferative therapy for HIV cure: a compound interest approach
journal, June 2017


Modelling HIV and MTB Co-Infection Including Combined Treatment Strategies
journal, November 2012


Recombination Enhances HIV-1 Envelope Diversity by Facilitating the Survival of Latent Genomic Fragments in the Plasma Virus Population
journal, December 2015

  • Immonen, Taina T.; Conway, Jessica M.; Romero-Severson, Ethan O.
  • PLOS Computational Biology, Vol. 11, Issue 12
  • DOI: 10.1371/journal.pcbi.1004625

Efficacy of the Post-Exposure Prophylaxis and of the HIV Latent Reservoir in HIV Infection
journal, June 2019

  • Pinto, Carla M. A.; Carvalho, Ana R. M.; Baleanu, Dumitru
  • Mathematics, Vol. 7, Issue 6
  • DOI: 10.3390/math7060515

Modelling microbial infection to address global health challenges
journal, September 2019

  • Fitzpatrick, Meagan C.; Bauch, Chris T.; Townsend, Jeffrey P.
  • Nature Microbiology, Vol. 4, Issue 10
  • DOI: 10.1038/s41564-019-0565-8

Cellular and molecular mechanisms involved in the establishment of HIV-1 latency
journal, February 2013


Modelling HIV and MTB Co-Infection Including Combined Treatment Strategies
journal, November 2012


Recombination Enhances HIV-1 Envelope Diversity by Facilitating the Survival of Latent Genomic Fragments in the Plasma Virus Population
journal, December 2015

  • Immonen, Taina T.; Conway, Jessica M.; Romero-Severson, Ethan O.
  • PLOS Computational Biology, Vol. 11, Issue 12
  • DOI: 10.1371/journal.pcbi.1004625

Epstein–Barr Virus: Diseases Linked to Infection and Transformation
journal, October 2016


Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy
journal, August 2011

  • Sigal, Alex; Kim, Jocelyn T.; Balazs, Alejandro B.
  • Nature, Vol. 477, Issue 7362
  • DOI: 10.1038/nature10347

Modelling microbial infection to address global health challenges
journal, September 2019

  • Fitzpatrick, Meagan C.; Bauch, Chris T.; Townsend, Jeffrey P.
  • Nature Microbiology, Vol. 4, Issue 10
  • DOI: 10.1038/s41564-019-0565-8

Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies
journal, April 2015

  • Crooks, Amanda M.; Bateson, Rosalie; Cope, Anna B.
  • Journal of Infectious Diseases, Vol. 212, Issue 9
  • DOI: 10.1093/infdis/jiv218

Modeling HIV Dynamics Under Combination Therapy with Inducers and Antibodies
journal, June 2019


Investigational treatment suspension and enhanced cell-mediated immunity at rebound followed by drug-free remission of simian AIDS
journal, January 2013


Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies
text, January 2015

  • Rosalie, Bateson,; M., Margolis, David; J., Eron, Joseph
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/mre9-5k02

Modeling the within-host dynamics of HIV infection
journal, September 2013


Advances in Developing CAR T-Cell Therapy for HIV Cure
journal, March 2020


A Highly Intensified ART Regimen Induces Long-Term Viral Suppression and Restriction of the Viral Reservoir in a Simian AIDS Model
journal, June 2012


HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days—Implications for HIV Remission
journal, July 2015